Myelofibrosis Drug Gets FDA Nod
(MedPage Today) — A kinase inhibitor billed as the first treatment specifically for the bone marrow disease myelofibrosis has won approval from the FDA, the agency announced.
Article printed from Gastroenterology Education and CPD for trainees and specialists: https://www.gastrotraining.com